 |
Webinar-RecordedWebinar-Understanding the Impact of Primary Packaging Decisions on Clinical Supply Success |
Primary packaging can greatly impact clinical manufacturing and requires more consideration to help make sure that IMPs are delivered efficiently, as well as ensure product stability, ease of use, and patient compliance. Primary packaging needs vary by study, so it is important to understand different packaging elements, as well as current trends and advancements in technology. Incorporating the appropriate primary packaging strategies can play a significant role in overall study success and help to minimize other risks.
Learn more about:
The impact that primary packaging can have on a study
What factors to consider when selecting a primary packaging format
How an experienced partner can provide invaluable guidance and offer creative solutions.
Why Catalent?
Catalyst + Talent
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
